ARTW
Art's-Way Manufacturing Co., Inc.
ARTW offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CAT
Caterpillar Inc.
CAT has the edge over ARTW overall, supported by stronger fundamentals.
ARTW Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Under pressure |
ARTW's revenue is currently stable, but its profitability, cash flow and balance sheet are under pressure.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
ARTW PE Valuation
ARTW has no meaningful PE right now: it lost money over the past year.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
ARTW Forward outlook
There aren't enough analyst estimates for ARTW to show an outlook.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
ARTW Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.09 | -118% |
| Q2 2026 | -$0.01 | -102% |
| Q1 2026 | $0.25 | +79% |
| Q4 2025 | $0.20 | +233% |
| Q3 2025 | $0.50 | +$0.68 |
| Q2 2025 | $0.44 | +$0.62 |
| Q1 2025 | $0.14 | +$0.25 |
| Q4 2024 | $0.06 | +20% |
ARTW has swung to a loss: it lost $0.09 per share over the past year, after a profit the year before.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the edge over ARTW on earnings quality, reporting a profit while its opponent remains loss making.
ARTW Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.6M | -13% |
| Q2 2026 | $7.9M | +24% |
| Q1 2026 | $6.6M | +29% |
| Q4 2025 | $5.1M | -18% |
| Q3 2025 | $6.4M | +9.5% |
| Q2 2025 | $6.3M | -5.8% |
| Q1 2025 | $5.1M | -10% |
| Q4 2024 | $6.2M | -10% |
ARTW's revenue is growing: $6M last quarter, down 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -1.3% | -6.6 points |
| Q2 2026 | 3.6% | -4.4 points |
| Q1 2026 | 5% | +4.9 points |
| Q4 2025 | -11% | -20 points |
| Q3 2025 | 5.4% | +2.7 points |
| Q2 2025 | 8.1% | +5.6 points |
| Q1 2025 | 0.1% | +6.7 points |
| Q4 2024 | 8.4% | +7.1 points |
ARTW's operating margin was −1.3% last quarter, down 6.6 points from the same quarter a year ago.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT has the edge over ARTW on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over ARTW on profitability, with a higher operating margin.
ARTW Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $12.9K | +$1.5M |
| Q2 2026 | $21.4K | -98% |
| Q1 2026 | -$28K | +$156.5K |
| Q4 2025 | -$1M | -196% |
| Q3 2025 | -$1.5M | -947% |
| Q2 2025 | $1.2M | +20% |
| Q1 2025 | -$184.5K | +$195.9K |
| Q4 2024 | $1.1M | +468% |
ARTW's free cash flow was −$1M over the past year, against $596,642 the year before.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT has the edge over ARTW on cash generation, producing positive trailing cash flow while its opponent burns cash.
ARTW Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +13.2K shares |
| 1 year | +1.9% | +95.4K shares |
| 3 years | +3.8% | +192K shares |
| 5 years | +15% | +672K shares |
| Available history | +22% | +924K shares |
ARTW has 5M diluted shares, up 1.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $1,693 |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $1,542 |
| Q4 2024 | — |
ARTW has spent almost nothing on buybacks in the past year.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over ARTW on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
ARTW Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.9x | Moderate |
| Q2 2026 | 2.0x | Moderate |
| Q1 2026 | 1.7x | Healthy |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 0.9x | Very low |
| Q2 2025 | 1.0x | Healthy |
| Q1 2025 | 1.2x | Healthy |
| Q4 2024 | 1.6x | Healthy |
ARTW's net debt is about 2.9 years of its operating earnings (EBITDA), up from less than a year a year ago.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has the edge over ARTW on leverage, with a lower net debt burden relative to earnings.
ARTW Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.9 | Neutral |
| Stochastic | 31.8 | Neutral |
ARTW's weekly RSI is 51 (neutral) and its Stochastic is 32 (neutral).
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
ARTW PE vs Industrials Sector
| Metric | ARTW | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
ARTW has no meaningful PE right now: it lost money over the past year.
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
ARTW Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.04 | 5.6% below |
| 20 week MA | $2.84 | 1.1% above |
| 50 week MA | $2.61 | 10% above |
| 100 week MA | $2.41 | 19% above |
| 200 week MA | $2.25 | 28% above |
ARTW has the edge over CAT on trend strength, trading above more of its moving averages.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 37% above its 200-week average.
ARTW Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.76 | $2.47 | +40% |
| 2021 | $2.47 | $3.36 | +36% |
| 2022 | $3.36 | $1.90 | -43% |
| 2023 | $1.90 | $2.07 | +8.9% |
| 2024 | $2.07 | $2.44 | +18% |
| 2025 | $2.44 | $2.38 | -2.5% |
| 2026 YTD | $2.38 | $2.87 | +21% |
ARTW has the edge over CAT on returns for 2026, with the stronger performance.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has finished every year since 2020 higher, and it's up 3.8% so far in 2026.